Foley Hoag LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Foley Hoag LLP’s patent prosecution team represents biotech companies, research institutions and market leaders. Co-head David Halstead handles complex patent strategies and freedom-to-operate matters, advising major biotech and pharmaceutical companies. Co-head Susan Abelleira advises top life sciences investors and companies on prosecution, and diligence, as well as managing global portfolios. Co-head Lucas Watkin focuses on patent advisory and portfolio management. Hathaway Russell secures critical patent protections for US and foreign clients, while DeAnn Smith works on patent strategy, prosecution, and portfolio value creation. Partners in Boston include all above; in New York, Stephen Kenny specializes in product clearance and patentability landscapes, and Erik Huestis advises clients on patent prosecution, PTAB proceedings, licensing, and corporate IP matters.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team at Foley Hoag is our go to team for our most important filings. They are extremely knowledge about worldwide patent practice and are extremely responsive and easy to work with.’
Key clients
- Annexon, Inc.
- UCLA
Work highlights
Advising Regeneron Pharmaceuticals, Inc. on patent strategy and prosecution to protect its VelociSuite platforms (including VelocImmune and VelociHum) and CAR‑T technologies, including portfolio development and strategy.